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  Historically, German chamomile (GC) oil has been used for 
treatment of skin disorders. BALB/c mice were sensitized 
twice a week with 100 μL of 1% 2,4-dinitrochlorobenzene 
(DNCB) and challenged twice the following week with 100 μL 
of 0.2% DNCB for atopic dermatitis induction. Thereafter, 
3% GC oil was applied daily (70 μL, 6 times week) on the 
dorsal skin for 4 weeks. Saline or jojoba oil was used for 
the control mice. Blood was collected after second DNCB 
challenge, and at 2 and 4 weeks after initiating oil application. 
Serum IgE levels were significantly lowered in the GC oil 
application group at the end of the 4-week application period. 
The GC oil application for 4 weeks resulted in reduction 
in  serum  IgG1  level  compared  with  that  after  2-week 
application.  The  GC  oil  application  group  showed  a 
significantly lower serum histamine level than the control 
group 2 weeks after oil application. Scratching frequency 
of  the  GC  oil  application  group  was  significantly  lower 
than either control groups. This study is to demonstrate 
GC oil’s immunoregulatory potential for alleviating atopic 
dermatitis through influencing of Th2 cell activation.
Keywords: atopic dermatitis, cytokine, German chamomile oil, 
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Introduction 
In general, atopic dermatitis occurs mainly from 
dysregulation in helper T (Th) cell reactivities [1,4]. The 
Th cell is classified into two types, types 1 and 2, depending 
on type of cytokine secreted by the cell and immunoregulatory 
functions driven by the secreted cytokine [11,22,29]. Any 
disruption of the balance between these two types of Th 
cells may cause a variety of immunological diseases, such 
as allergic asthma and allergic rhinitis. Atopic dermatitis is 
an immunologic disease induced from an imbalance 
favoring type-2 helper T (Th2) cell [3]. 
Interleukin-4 (IL-4) production from Th2 cells, mast 
cells, or other immune components cells is known to 
trigger isotype-switching to IgE and IgG1 in B cells [18]. 
Evaluation of IL-4 production from splenic T cells is a tool 
for investigating the predominance of Th2 reactivity [13]. 
Hyper IgE production is a hallmark of atopic dermatitis in 
humans [1,4], and well documented in transgenic mice or 
NC/Nga mice suffering from atopic dermatitis-like skin 
lesions [8,26,33]. IFNγ from type-1 helper T (Th1) cells, 
natural killer cells, other immune cells induces isotype- 
switching to IgG2a in mice [17,31]. Therefore, analysis of 
the serum IgG1 or IgG2a levels could reflect the alteration 
of homeostasis between type-1 and type-2 immune 
responses. Since histamine is immediately released 
following allergen exposure, increase in serum histamine 
level is often considered as a parameter for diagnosing the 
onset of allergic diseases. Previous studies also showed 
that eosinophils play an important role in atopic dermatitis, 
characterized by elevated blood eosinophil counts [17,30].
Atopic dermatitis is a chronic skin disorder and has been 
medically treated using steroids, antihistamines, 
immunosuppressive agents, and other medications. But 
many studies have reported that long-term use or even 
abuse of these agents may cause various side effects, so 
relevant recent studies have focused upon complementary 
therapies based on alternative medicine [9,28].
Aromatic oils are natural essential oils consisting of 
volatile organic compounds containing original scents and 
therapeutic substances. It is well known for positive effects 
in insomnia, relief from anxiety and stress, recovery from 
fatigue, muscular relaxation, anti-histaminic or anti-allergic 
actions [5,7,27]. German chamomile (GC) oil, an aromatic 
oil, has been reported to help relieve physical or mental 
stress or fatigue through its sedative or alleviating effects 
along with fruity scent, is also known to be effective in the 36    Soon-Hee Lee et al.
Fig. 1. Macroscopic photograph of atopic dermatitis mouse skin 
just after induction by the application of 2,4-dinitrochlorobenzene
(DNCB) (A). Saline application after atopic dermatitis induction
as the control (B), jojoba oil application after atopic dermatitis 
induction as the vehicle (C), and German chamomile (GC) oil 
application after atopic dermatitis induction as the experiment (D).
B, C and D are macroscopic photographs at 4 week after various
application.
treatment of dry and itchy skin [23]. Historically, GC oil 
has been used for the treatment of skin disorders such as 
eczema, as it contains three major sesquiterpene constituents 
(azulene, bisabolol, farnesene) with anti-inflammatory or 
anti-histaminic effects [6,32]. Particularly, it is known that 
these effects of GC oil come from α-bisabolol, a substance 
that has strong anti- inflammatory effects of all. However, 
there have been no scientific studies to date on the possible 
effects of GC oil on alleviating atopic dermatitis. Therefore, 
this study tested the application of GC oil on BALB/c mice 
demonstrating atopic dermatitis-like immune alteration 
and skin lesions. The 2,4-dinitrochlorobenzene (DNCB) 
skin application model was adopted to induce atopic 
dermatitis-like phenomena in mice, which has been reported 
as a reliable model demonstrating similar immunologic 
and skin alteration as human atopic dermatitis [24]. 
Materials and Methods
Composition of GC oil
For the experiment, this study used GC oil (Sanoflore, 
France) as 100% pure and natural essential oil tested by 
organic product certification organization (ECOCERT, 
France) as well as jojoba oil (Desert Whale, USA). Jojoba 
oil was used as a control due to its clinical application.
Animals
Forty BALB/c mice (SPF male, 7 weeks old) were 
purchased from Daehan Biolink (Korea). Both animal care 
and protocol for this study were in accordance with 
Institutional Animal Care and Use Committee (USA) and 
OECD guideline. Animals fed on unlimited amount of water 
and feed throughout whole experiment duration. The 
animals were divided into four groups (ten mice each) and 
were housed separately in plastic cages per each group. The 
normal group was applied with saline throughout atopic 
dermatitis induction stage and oil treatment period. The 
control group was applied with saline following induction 
of atopic dermatitis. The vehicle group was applied with 
jojoba oil and the experimental group with 3% GC oil 
following atopic dermatitis induction (Fig. 1). Three % GC 
oil was selected in accordance to the clinical application.
Induction  of  atopic  dermatitis-like  immunologic 
and skin disorders
For induction of atopic dermatitis-like immunologic and 
skin disorders, DNCB was applied onto mice skin. After 
complete removal of dorsal hairs in area of approximately 
8 cm
2, 100 μL of 1% DNCB was applied on their dorsal skin 
twice every 3 days for sensitization. In the next week, 100 
μL of 0.2% DNCB was applied on their dorsal skin twice 
every 3 days for challenge. DNCB was dissolved in a 4 : 1 
mixture of acetone and olive oil. As soon as the challenge 
was completed, 3% GC oil (diluted in jojoba oil) was applied 
once a day (70 μL, 6 times week) on the dorsal skin for 4 
weeks. Saline or jojoba oil was applied onto skin of the 
control mice. Three hundreds μL of blood was sampled at 
the completion of second challenge and 2 weeks after 
initiating oil application via periorbital sinus. After the 4-week 
oil application period, under ether anesthesia blood sampled 
from posterior vena cava was used for immunologic or 
hematologic analysis, and skin tissue was sampled and fixed 
with 10% neutral buffered formalin solution for histopathologic 
examinations, splenic cells were sampled by separation 
from the extracted spleen and stored in a freezer after 
freezing in liquid nitrogen for cytokine analysis. 
Immunologic observation 
Measurement of serologic parameters: Serum IgE levels 
were determined using a sandwich ELISA method, as 
previously described [15]. The levels of serum IgG1 and 
IgG2a were also determined using a sandwich ELISA 
method, using goat anti-mouse IgG1 and IgG2a capture 
antibodies and a peroxidase conjugated anti-mouse IgG 
detection antibody [16]. In addition, serum histamine levels 
were determined using the IBL histamine ELISA kit (IBL, 
Germany) according to the quantification methodology of 
Duda et al. [10].
Measurement of IL-4 in splenic cell culture solution: 
Splenic cells (5 × 10
5 cells) were stimulated with 
immobilized anti-CD3 mAb (5 μg) for 48 h in a CO2 
incubator. The level of IL-4 in culture supernatants was 
determined using a sandwich ELISA method prepared by 
BD Pharmingen (BD, USA) [15]. The lower limit of Effects of German chamomile oil on atopic dermatitis    37
Table 1. Serum level of IgG1 or IgG2a (mg/mL) in mice following
atopic dermatitis induction and test compounds application
Group*
Week after the completion
of the second DNCB
† challenge
‡
024
IgG1
  Normal
  Control
  Vehicle
  Experiment
IgG2a
  Normal
  Control
  Vehicle
  Experiment
2.34 ± 0.53
a
6.24 ± 0.39
b
 7.95 ± 0.84
bc
9.24 ± 0.94
c
0.64 ± 0.06
a
1.30 ± 0.16
b
1.75 ± 0.21
b
1.58 ± 0.17
b
5.13 ± 1.03
a
11.09 ± 1.58
ab
15.90 ± 2.07
ab
19.80 ± 6.03
b
8.88 ± 2.28
a
8.40 ± 2.39
a
16.73 ± 2.03
b
12.09 ± 2.58
ab
 6.90 ± 1.15
a
10.18 ± 0.83
ab
15.12 ± 1.63
c
13.75 ± 1.69
bc
  8.96 ± 2.41
ab
 8.30 ± 1.61
a
15.56 ± 1.52
b
10.89 ± 2.53
ab
*Normal: No atopic dermatitis induction, Control: Saline application
after atopic dermatitis induction, Vehicle: Jojoba oil application after
atopic dermatitis induction, Experiment: GC oil application after 
atopic dermatitis induction. 
†DNCB: 2,4-dinitrochlorobenzene. 
‡The
results are expressed as means ± SE (n = 10). 
a,b,cValues with different
superscripts in the same column are significantly different (p ＜ 0.05).
Fig. 2. GC oil-mediated suppression of IgE hyperproduction. 
Serum IgE levels were measured at the completion of second DNCB
challenge, 2 and 4 weeks after initiating dermal application of test
compounds. The results are expressed as means ± SE. 
a,b,cValues 
with different superscripts are significantly different (p ＜ 0.05).
Fig. 3. Changes in serum histamine levels of the mice sensitized and
challenged with DNCB followed by 4-week dermal application of
test compounds. The results are expressed as means ± SE. 
a,bValues
with different superscripts are significantly different (p ＜ 0.05).
detection was 5 pg/mL for IL-4. 
Behavioral observation
Behaviors of mice were monitored according to 
observation methodology of Kobayashi et al. [20]. The 
frequency of scratching occurring on facial or dorsal skins 
was counted with a 30-min visual observation on the first 
day and on the 21st day after GC oil application.
Data analysis
All data collected in this study were statistically processed 
via SPSS WIN (SPSS, USA). ANOVA was used to test for 
differences among the groups. Post-hoc analysis was 
carried out using the Duncan’s multiple range test to test 
for significant difference among the means (p ＜ 0.05). 
Results
GC oil-mediated suppression of IgE hyperproduction
Mice at the completion of 0.2% DNCB second challenge 
demonstrated significantly higher levels of serum IgE 
(approximately 4.4 times) than the normal group (Fig. 2), 
implying a successful induction of atopic dermatitis-like 
immune alteration. Serum IgE levels were significantly 
downregulated in the experimental group after application 
of GC oil for 4-weeks, while the saline-applied control or 
the jojoba oil-applied vehicle groups still demonstrated 
significantly upregulated IgE levels compared to the 
normal mice.
Modulation of serum IgG1 level following GC oil 
application
Levels of IgG1 and IgG2a were substantially increased 
following DNCB sensitization and challenge compared to 
the normal mice (Table 1). Application of GC oil for 4 
weeks resulted in a reduction of approximately 31% (13.75 
mg/mL) in IgG1 levels compared to 19.80 mg/mL after 
2-weeks of GC oil application. There were no significant 
differences in the levels of IgG1 in saline-applied control 
or jojoba oil-applied vehicle groups between at 2 week and 
at 4 week following atopic dermatitis induction. Meanwhile, 
persistent application of GC or jojoba oil did not lead to 
any changes in IgG2a levels when compared between 2 
and 4 weeks following the induction of atopic dermatitis.38    Soon-Hee Lee et al.
Fig. 4. Effect of GC oil application on production of interleukin-4
(IL-4) from splenic T cells. Splenocytes were stimulated with 
immobilized anti-CD3 mAb for 48 h. Culture supernatants were 
collected for measurement of IL-4. The results are expressed as 
means ± SE.
Fig. 5. Decreased scratching frequency in GC oil-treated mice. 
Frequency of scratching on facial and back skin was measured 
for 30 min one day after the second DNCB challenge (day 1) and
the 21st day after initiating GC oil application (day 21). The 
results are expressed as means ± SE. 
a,b,cValues with different 
superscripts are significantly different (p ＜ 0.05).
Table 2. Changes in number of inflammatory cells in GC oil-treated
mice skin at 4 week after various application following atopic 
dermatitis induction
Group Neutrophils* Lymphocytes*
Normal
Control
Vehicle
Experiment
1.20 ± 0.13
a
1.90 ± 0.23
b
 1.50 ± 0.17
ab
1.30 ± 0.15
a
2.00 ± 0.26
a
4.20 ± 0.42
c
3.20 ± 0.25
b
2.30 ± 0.26
a
*The results are expressed as means ± SE (n = 10) of microscopic 
observation at ×200 magnification. 
a,b,cValues with different 
superscripts in the same column are significantly different (p < 0.05).
Normal: No atopic dermatitis induction, Control: Saline application
after atopic dermatitis induction, Vehicle: jojoba oil application after
atopic dermatitis induction, Experiment: GC oil application after 
atopic dermatitis induction.
Effect of GC oil application on modulation of serum 
histamine level
Histamine levels were significantly higher in all mice 
groups exposed to DNCB compared to the normal mice 
(Fig. 3), indicating a successful induction of atopic 
dermatitis-like alterations of the immune system. Two 
weeks after GC oil application, the GC oil group (18.45 
ng/mL) showed significantly lower (approximately 51%) 
serum histamine level than the saline-applied control 
(37.43 ng/mL), and also lower (approximately 40%) than 
the jojoba oil-applied vehicle (30.60 ng/mL) group. 
However, no further downregulation of histamine levels 
was found 4 weeks after the start of treatment. 
Effect of GC oil application on production of IL-4 
from splenic T cells
Four weeks of GC oil application (10.4 pg/mL) resulted 
in lower (approximately 50%) IL-4 production with no 
statistical significance (p ＞ 0.05) in splenic cell culture 
supernatants compared to the saline treated control mice 
(20.7 pg/mL) (Fig. 4). These findings imply that GC oil 
controls the production of IL-4 from Th2 cells, contributing 
to controlling IgE and IgG1 generation from B cells. 
Decreased scratching frequency in GC oil-applied mice
The frequency of scratching on facial and back skin was 
observed for 30-min on one day after the second DNCB 
challenge (day 1) and on the 21st day after initiating GC oil 
application (day 21). It was found that the GC oil group (44 
times) and jojoba oil group (65 times) showed significantly 
lower (approximately 45% and 19%, respectively) scratching 
frequency than the saline treated control group (80 times) 
at day 21 (Fig. 5). Furthermore, scratching frequency of the 
GC oil group was significantly lower (approximately 32%) 
than the jojoba oil vehicle group.
Decreased  inflammatory  cell  infiltration  in  GC 
oil-applied mice skin
Numerous leukocytes were infiltrated into the dermis and 
epidermis was thickened in the control mouse skin 
compared to the normal mouse skin, while inflammatory 
cell infiltration, such as neutrophils and lymphocytes, and 
hyperplasia of the epidermis were significantly (p ＜ 0.05) 
reduced in the experimental mouse skin (Table 2 and Fig. 
6). In this study, it was found that application of GC oil for 
4 weeks resulted in significantly lower leukocytes in the 
peripheral blood than the saline treated control mice, and 
showed similar values to the normal mice (Table 3). The 
number of neutrophils, lymphocytes, monocytes, eosinophils 
and basophils of GC oil application for 4 weeks showed 
significantly (p ＜ 0.05) lower levels than the saline treated Effects of German chamomile oil on atopic dermatitis    39
Fig. 6. Histophatological findings at 4-week after various application
following atopic dermatitis induction. No atopic dermatitis induction
as normal mice (A), saline application following atopic dermatitis
induction as control mice (B), jojoba oil application following 
atopic dermatitis induction as vehicle mice (C), and GC oil 
application following atopic dermatitis induction as experimental
mice (D). H&E stain, ×100.
Table 3. Changes in number of leukocytes at 4 week after various application following atopic dermatitis induction
Items
Group 
Normal Control Vehicle Experimental
Total WBC
Neutrophils
Lymphocytes
Monocytes
Eosinophils
Basophils
3.39 ± 0.33
a
1.03 ± 0.12
a
2.01 ± 0.17
a
0.29 ± 0.05
a
0.04 ± 0.01
a
0.02 ± 0.01
ab
5.21 ± 0.32
b
1.53 ± 0.13
b
2.95 ± 0.19
b
0.59 ± 0.04
b
0.10 ± 0.03
b
0.04 ± 0.01
b
3.87 ± 0.26
a
1.16 ± 0.06
a
2.32 ± 0.20
a
0.34 ± 0.03
a
0.04 ± 0.01
a
0.02 ± 0.01
a
3.46 ± 0.19
a
1.05 ± 0.04
a
1.99 ± 0.15
a
0.34 ± 0.02
a
0.05 ± 0.01
a
0.02 ± 0.01
ab
The results are expressed as means ± SE (n = 10). 
a,bValues with different superscripts in the same row are significantly different (p ＜ 0.05).
Unit: ×10
9/L.
control mice by 31, 33, 42, 50 and 50%, respectively (Table 3).
Discussion
The present study was undertaken to evaluate the efficacy of 
GC oil alleviating atopic dermatitis-like immune alterations 
in mice. Even though GC oil has been historically used for 
the treatment of pruritic skin disorder [2,6,12,32], there has 
been no scientific study investigating GC oil on the 
treatment or prevention of atopic dermatitis. Our study is 
the first to demonstrate GC oil’s immunoregulatory potential 
for alleviating atopic dermatitis through influencing of Th2 
cell activation. Overall, we found that GC oil possessed an 
ability to influence Th2 cell activation involved with the 
onset or progression of atopic dermatitis, in that dermal 
application of GC oil resulted in the suppression of IgE or 
IgG1 over-production, downregulation of IL-4 production 
from Th2 cells, and demonstrated a reduction in histamine 
release. In addition, frequent scratching due to itchy 
sensations was alleviated following GC oil application 
onto the damaged skin involved with the pathogenesis of 
atopic dermatitis. 
Histamine release from activated mast cells or basophils 
is a hallmark of the occurrence of allergic diseases such as 
atopic dermatitis, and cause itching, increased vascular 
permeability, and the wheal and flare response of immediate 
hypersensitivity [1]. Pruritus is a symptom found in a 
variety of skin disorders like atopic dermatitis and contact 
allergic dermatitis. For atopic dermatitis cases, it has been 
reported that scratching due to itchy sensations causes skin 
damage, promotes inflammation and thereby further 
aggravates pruritus [1,4,21,34,35]. Therefore, it is important 
to reduce itchy sensations and scratching frequency to prevent 
aggravation of skin lesions due to pruritic disorders and 
improving quality of life. 
Kobayashi et al. [19,20] reported that the oral administration 
of GC extract combined with histamine receptor antagonists 
was more effective for the suppression of scratching 
behavior in mice than administration of histamine receptor 
antagonists alone. GC oil may inhibit the binding of 
histamine to its receptor, which will eventually control 
histamine mediated clinico-pathologic effects such as itching 
[20]. Concerning our results showing the downregulation 
of serum histamine levels 2 weeks after the start of GC oil 
application following atopic dermatitis induction, this 
compound may also exhibit its anti-histamine effect by 
directly suppressing histamine release from mast cells 
through downregulation of IL-4 production from Th2 cells 
and following by suppression of IgE or IgG1 over-production. 
The most important aspect to be discussed is GC oil’s 
systemic effect on the modulation of the in vivo type-2 
response. The type-2 response becomes predominant when 40    Soon-Hee Lee et al.
differentiation or activation of Th2 cells is preferred, but 
development or stimulation of Th1 cells is suppressed 
[13,14]. Considering that the skewedness toward type-2 
responses is a background mechanism for the occurrence 
of atopic dermatitis [1,4,25], dermal application of GC oil 
could systematically block the pathogenesis of atopic 
dermatitis through correcting the immune homeostasis 
skewed in favor of Th2. Considering our experimental 
results, it could be concluded that the application of GC oil 
on the skin of atopic dermatitis cases could alter production 
of IL-4 from Th2 cells and also alter IgE, IgG1 and histamine 
production, performing a series of immunoregulatory 
functions to alleviate the occurrence or progression of 
atopic dermatitis. Hence, it is believed that the application 
of GC oil on atopic dermatitis cases will be significantly 
meaningful for public health and alternative medicine.
Although it is known that α-bisabolol has the strongest 
anti-inflammatory effects of all the constituents of GC oil, 
it is not clear which constituent(s) of GC oil contribute to 
the GC oil-mediated alleviation of atopic dermatitis-like 
immunologic and skin alterations in mice at the moment. 
Future studies will be directed towards identifying which 
components of GC oil are responsible for its 
immunomodulatory effects. Furthermore, whether GC oil 
exerts its immunomodulatory effects independently, 
sequentially, or concomitantly on each of the immune 
component cells involved in the pathogenesis of atopic 
dermatitis such as Th, B, and mast cells needs to be 
answered. Further investigations are necessary to identify 
target immune cells for GC oil-mediated alleviation of 
atopic dermatitis-like immunologic and skin alterations. 
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